Symptoms (e.g. breathlessness, orthopnoea, ankle swelling, fatigue), signs (e.g. elevated jugular venous pressure, peripheral oedema, third heart sound) or established diagnosis of HF with LV ejection fraction ≥ 50%, or
Meets HFpEF diagnostic criteria in accordance with the HFA-PEFF diagnostic algorithm form the Heart Failure Association of the European Society of Cardiology, in which a score ≥5 points confirms diagnosis of HFpEF
You may not be if
Known diagnosis of Type 1 Diabetes
Pregnancy or breast-feeding or females of child bearing age without a negative pregnancy test
Receiving an investigational drug or device within 30 days prior to participating in the study
Decompensated heart failure or pulmonary oedema
History of prolonged corrected QT interval or torsades de pointes
Second- or third-degree atrioventricular block
Abnormal liver function tests (\> 3x upper limit of normal) or history of liver disease
Baseline eGFR \< 30mL/min/1.73m2
Any contraindications to MRI including implanted devices/pacemakers
Severe native valve disease, restrictive cardiomyopathy, constrictive pericarditis or hypertrophic cardiomyopathy, myocarditis or takotsubo cardiomyopathy.
Recent myocardial infarction within the previous 3 months